Clinical Trial

An Observational Study of Patients With Chronic Gastrointestinal Disease

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
TARGET-GASTRO is an observational research study to conduct a comprehensive review of outcomes for patients with the chronic gastrointestinal (GI) diseases: eosinophilic gastrointestinal disease (EGID), ulcerative colitis (UC) or Crohn's disease (CD).
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-03-07; most recent amendment 2026-01-27.
Status change: Not Yet Recruiting → Active, Not Recruiting 2024-10-17
Trial Details
NCT Number NCT05774080
Lead Sponsor Target PharmaSolutions, Inc.
Conditions Gastrointestinal Diseases
Enrollment 500,000 participants
Start Date 2023-08-01
Primary Completion 2037-12 (estimated)
Study Completion 2037-12 (estimated)
Updated on ClinicalTrials.gov 2026-01-29